BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 18249368)

  • 1. The incidence of both serious and minor complications in young women undergoing oocyte donation.
    Maxwell KN; Cholst IN; Rosenwaks Z
    Fertil Steril; 2008 Dec; 90(6):2165-71. PubMed ID: 18249368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
    Hernández ER; Gómez-Palomares JL; Ricciarelli E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US oocyte donors: a retrospective study of medical and psychosocial issues.
    Kramer W; Schneider J; Schultz N
    Hum Reprod; 2009 Dec; 24(12):3144-9. PubMed ID: 19729378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
    Bodri D; Guillén JJ; Polo A; Trullenque M; Esteve C; Coll O
    Reprod Biomed Online; 2008 Aug; 17(2):237-43. PubMed ID: 18681998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases.
    Sauer MV
    Am J Obstet Gynecol; 2001 Feb; 184(3):277-8. PubMed ID: 11228473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of multiple cycles in oocyte donors.
    Jain A; Robins JC; Williams DB; Thomas MA
    Am J Obstet Gynecol; 2005 May; 192(5):1382-4. PubMed ID: 15902115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial.
    Garcia-Velasco JA; Quea G; Piró M; Mayoral M; Ruiz M; Toribio M; Requena A
    Fertil Steril; 2009 Jul; 92(1):222-5. PubMed ID: 18710719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.
    Escribá MJ; Bellver J; Bosch E; Sánchez M; Pellicer A; Remohí J
    Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment.
    Gorkemli H; Camus M; Clasen K
    Arch Gynecol Obstet; 2002 Nov; 267(1):4-6. PubMed ID: 12410364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors.
    Stoop D; Vercammen L; Polyzos NP; de Vos M; Nekkebroeck J; Devroey P
    Fertil Steril; 2012 Jun; 97(6):1328-30. PubMed ID: 22464081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocytes in the empty follicle: a controversial syndrome.
    Aktas M; Beckers NG; van Inzen WG; Verhoeff A; de Jong D
    Fertil Steril; 2005 Dec; 84(6):1643-8. PubMed ID: 16359958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
    Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
    Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian salvage in bilaterally complicated severe ovarian hyperstimulation syndrome.
    Al Omari W; Ghazal-Aswad S; Sidky IH; Al Bassam MK
    Fertil Steril; 2011 Aug; 96(2):e77-9. PubMed ID: 21718996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome.
    Grynberg M; Berwanger AL; Toledano M; Frydman R; Deffieux X; Fanchin R
    Fertil Steril; 2011 Oct; 96(4):869-71. PubMed ID: 21839435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception.
    Ulug U; Ben-Shlomo I; Bahceci M
    Fertil Steril; 2004 Aug; 82(2):338-42. PubMed ID: 15302281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal colon cancer in a young egg donor: a physician mother's call for follow-up and research on the long-term risks of ovarian stimulation.
    Schneider J
    Fertil Steril; 2008 Nov; 90(5):2016.e1-5. PubMed ID: 18314117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
    Lavery SA; El-Shawarby SA; Turner C; Trew G
    Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies.
    Krieg SA; Henne MB; Westphal LM
    Fertil Steril; 2008 Jul; 90(1):65-70. PubMed ID: 17727845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies.
    Budak E; Garrido N; Soares SR; Melo MA; Meseguer M; Pellicer A; Remohí J
    Fertil Steril; 2007 Aug; 88(2):342-9. PubMed ID: 17335819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.